ARTV
NASDAQ · Biotechnology
Artiva Biotherapeutics Inc
$10.99
-0.31 (-2.74%)
Open$11.27
Previous Close$11.30
Day High$11.28
Day Low$10.80
52W High$14.53
52W Low$2.22
Volume—
Avg Volume359.5K
Market Cap552.46M
P/E Ratio—
EPS$-3.43
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
-25.9% upside
Current
$10.99
$10.99
Target
$8.14
$8.14
$7.28
$8.14 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 567.1K | 1.13M | 14.43M |
| Net Income | -147,662,558 | -265,527,077 | -2,421,627 |
| Profit Margin | -26,045.0% | -24,742.8% | -16.8% |
| EBITDA | -154,251,730 | -292,785,501 | -2,990,686 |
| Free Cash Flow | — | — | -1,604,262 |
| Rev Growth | -50.0% | -50.0% | +14.0% |
| Debt/Equity | 0.00 | 0.00 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |